ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
The company issued a corrigendum to its FY 2025-26 Annual Report. This update corrects financial highlights, auditor report details, and capital management tables.
Fischer Medical Ventures will invest ₹49.88 Crore into its three material wholly-owned subsidiaries via rights issues to support capital expansion.
Fischer Medical Ventures published a Chairman's Letter outlining its Radiology, Preventive Healthcare and Wellness segments plus Indonesia and Philippines deployments. No new transaction, order or capital event is announced.
Fischer Medical Ventures Limited has submitted its Annual Report for the financial year 2025-2026 as per SEBI regulations. The document is available on the company website.
Fischer Medical Ventures Limited has scheduled its 33rd Annual General Meeting on September 29, 2026, through video conferencing. The company also announced the e-voting and book closure dates.
Fischer Medical Ventures is building an AI-enabled healthcare platform integrating medical imaging, screening, and hospital digitization. Strategy focuses on vertically integrated IP across magnets, coils, and AI diagnostics.
Fischer Medical Ventures (FMV) presentation outlines a vertically integrated AI healthcare ecosystem spanning medical imaging, screening, and hospital digitization through subsidiaries like Time Medical and FlynnCare.
Fischer Medical Ventures Limited has fixed September 22, 2026, as the record date for its upcoming dividend. The 33rd Annual General Meeting is scheduled for September 29, 2026.
Fischer Medical Ventures Limited appointed Mr. David Yeow as an Additional Independent Director for five years. The company also reconstituted its Audit Committee and scheduled its 33rd AGM.